If phase 3 trial fails again and inevitably the stock falls again then, what are other bullish cases to keep holding it long term?
I bought into this because of possible success of this dermatomyositis drug, but if it fails, what are bullish cases for the stock then? What would be the next moves for the company?
Posted Apr 7, 2021, 2:13 PM UTC
Correct me if I'm wrong, but the shareholders are voting in May to double the float. If they do that while it is near the current price level, they risk being under a $1 for over 30 days and getting delisted from the NYSE. If the insiders knew there was a high risk of an even further decrease in the near future with a trial failure, instead of success pushing the price up, why would they be voting on something that would push the price down even further, almost guaranteeing that they are delisted?